Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	17.01	68.27	58.34
Graham Fair Price	-11.81	11.52	13.07
PEG	62.82	-1.61	0.99
Price/Book	0.60	2.62	2.60
Price/Cash Flow	-0.46	99.52	99.98
Prices/Earnings	15.13	29.21	25.37
Price/Sales	5.54	20.55	19.47
Price/FCF	-0.46	99.52	99.98
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-7.31	0.63	0.68
Operating Margin	-18.93	0.21	0.26
ROA	-13.00	0.01	0.02
ROE	0.03	0.02	-12.62
ROIC	0.02	0.02	-26.62
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.07	0.09	-22.58
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.38	-0.27	-29.80
EPS QOQ	0.26	-0.18	-29.29
FCF QOQ	0.19	-0.04	-75.91
Revenue QOQ	0.07	-0.10	41.50
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	218.60	212.03	-3.01
Days Sales Outstanding (DSO)	91.15	67.46	-25.99
Inventory Turnover	0.41	0.42	3.10
Debt/Capitalization	0.29	0.29	2.68
Quick Ratio	1.46	1.21	-17.23
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	17.20	16.23	-5.66
Cash	4.78	4.03	-15.73
Capex	-0.24	-0.17	26.69
Free Cash Flow	0.45	0.43	-4.66
Revenue	2.30	2.07	-10.07
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.99	1.84	-7.31
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.07	6.49	27.98
Naive Interpretation	Member

06 - Financial Health · Weak

Rating